The regulator has introduced 12 new performance indicators for polyclinics

Adjustments were made to the order of the ministry No. 44 of February 10, 2023 “On approval of the Requirements for the structure and content of the tariff agreement” - the document defines the tariffs and methods of payment for medical care under the compulsory medical insurance at the subject level.

Since 2022, the order also contains performance targets that the federal regulator proposes to include in tariff agreements and for the fulfillment of which medical organizations receive additional funds. The rules for calculating bonuses are contained in the annually updated methodological recommendations for paying for medical care using compulsory medical insurance funds.

Taking into account the amendments, the current version of the list includes 33 criteria for the effectiveness of polyclinics instead of the previous 25. The regulator added or completely revised 12 indicators, and four more indicators retained their previous essence, but were clarified.

Thus, now the polyclinic will receive additional funds only if it conducts the required number of examinations among adults from 18 to 65 years old who have not appeared for a medical examination for two years. The requirements for the dispensary observation of citizens with malignant neoplasms have become stricter. For example, criteria have appeared for the share of detected suspicions of malignant neoplasms of the respiratory organs and prostate gland.

The system for monitoring the outpatient observation of patients with cardiovascular diseases was also modernized.

For the first time, the list includes criteria that are directly related to quality and volume control in the compulsory medical insurance sector. A clinic will receive additional points if fewer violations of the quality of medical care are identified that lead to a deterioration in the patient's health, disability or death. They will also monitor the reduction of unjustified refusals of treatment to insured persons.

All criteria related to COVID-19 were excluded from the list.

The list of performance indicators is updated periodically; the last time in 2023, mortality of the assigned population was excluded from it.

According to the Federal Compulsory Medical Insurance Fund, by the end of 2024, medical organizations received 10.2 billion rubles on top of the usual per capita funding for a high percentage of performance indicators. One organization had an average of an additional 4 million rubles, and in 2023 the figure was noticeably lower - 2.5 million rubles, and in 2022 , on the contrary, higher - 3.1 million rubles.

The Russian Ministry of Health and the Federal Compulsory Medical Insurance Fund are confident that the introduction of such a bonus system has created conditions for “financial interest of medical workers in the early detection of diseases, their high-quality treatment, the level of health of the assigned population, and the life expectancy of patients.”